News 2023-06-23
Porton Pharma Solutions Welcomes Dr. Wenfang Miao as CEO of Porton USA, L.L.C. and J-STAR Research, Inc., Ushering in a New Era of Pharmaceutical Innovation
Join us in welcoming Dr. Wenfang Miao (Renee) as the new CEO of Porton USA, L.L.C. and J-STAR Research, Inc., and Vice-President of Porton Pharma Solutions, LTD. Dr. Miao brings with her more than 25 years of experience in technical, operational, and strategic leadership within the pharmaceutical industry as she will navigate Porton’s overall business strategies, operations, and business development and growth in the United States. We are looking forward to Porton’s stronger foothold in pharmaceutical innovation with her leadership. We are rooting for you, Dr. Miao!
Others
More
News 2026-09-17
Porton Congratulates Partner Acepodia on FDA and NMPA IND Approvals for ACE723, a Dual-Payload ADC
This project demonstrates Porton's process-development and scale-up capabilities for complex conjugates and adds to its experience supporting innovative biopharma companies worldwide.
News 2026-09-15
Porton Chongqing Liangjiang Drug Product Manufacturing Site Earns Recertification of ISO 14001 & ISO 45001
This successful recertification highlights the standardized operation of the site's management systems, the rigor of its on-site management, and the robustness of its risk control mechanisms, further validating the continued effectiveness of the dual systems.
